Live Breaking News & Updates on Peter Maag|Page 15

Stay updated with breaking news from Peter maag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Peter Maag Sells 2,432 Shares of CareDx, Inc (NASDAQ:CDNA) Stock

CareDx, Inc (NASDAQ:CDNA – Free Report) Director Peter Maag sold 2,432 shares of the business’s stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $8.72, for a total transaction of $21,207.04. Following the sale, the director now owns 313,136 shares of the company’s stock, valued at approximately […] ....

Raymond James , Peter Maag , Craig Hallum , Caredx Inc , Royce Associates , Ameriprise Financial Inc , Geode Capital Management , Squarepoint Ops , Goldman Sachs Group , Caredx Company Profile , Free Report , Director Peter Maag , Street Group , Capital Management , Allosure Kidney , Allomap Heart , Allosure Heart , Allosure Lung , Caredx Daily , Nasdaq Cdna , Insider Trading , Nsider Trades ,

Peter Maag Sells 2,432 Shares of CareDx, Inc (NASDAQ:CDNA) Stock

CareDx, Inc (NASDAQ:CDNA – Free Report) Director Peter Maag sold 2,432 shares of the stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $8.72, for a total value of $21,207.04. Following the completion of the sale, the director now directly owns 313,136 shares in the company, valued […] ....

Raymond James , Peter Maag , Metlife Investment Management , Alphacrest Capital Management , Caredx Inc , Us Bancorp , Cetera Advisor Networks , Goldman Sachs Group , Securities Exchange Commission , Free Report , Director Peter Maag , Exchange Commission , Advisor Networks , Crest Capital Management , Life Investment Management , Rhumbline Advisers , Allosure Kidney , Allomap Heart , Allosure Heart , Allosure Lung , Caredx Daily , Nasdaq Cdna , Insider Trading , Nsider Trades ,

Kyverna Therapeutics Announces First Patient Enrolled in Phase 1 Clinical Trial of CD19 CAR T-cell Therapy for Lupus Nephritis in the U.S.

Kyverna Therapeutics Announces First Patient Enrolled in Phase 1 Clinical Trial of CD19 CAR T-cell Therapy for Lupus Nephritis in the U.S.
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Peter Maag , National Institutes Of Health , Lupus Nephritis , National Institutes , Nature Reviews Rheumatology , Chronic Kidney , Nature Medicine ,